查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085475

DNA和RNA樣品製備市場：2026-2032年全球市場預測（按產品類型、技術、樣品類型、應用和最終用戶分類）

DNA-RNA Sample Preparation Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，DNA 和 RNA 樣品製備市場將成長至 45.6 億美元，複合年成長率為 9.49%。

主要市場統計數據
基準年 2025 24.2億美元
預計年份：2026年 26.3億美元
預測年份 2032 45.6億美元
複合年成長率 (%) 9.49%

DNA和RNA樣本製備是支援次世代定序（NGS）、PCR/qPCR、數位PCR、分子診斷、細胞和基因治療研究、液態生物檢體、感染疾病監測以及多體學工作流程的基礎技術。可靠的核酸萃取、純化、片段化、標靶濃縮和去除以及樣品製備決定了下游儀器能否產生臨床和科學上有效的結果。

對於技術供應商而言，該市場受以下因素驅動：從少量樣本中獲得高產量、在FFPE組織和血漿中實現可重複性，以及與自動化工作站的兼容性。基因組學計畫的擴展、分散式分子檢測和腫瘤生物標記的應用，以及基於RNA的分析在轉錄組學和病原體檢測中的持續使用，都推動了這一成長。

樣品製備領域的變革性變化

該領域正從依賴技術人員的手動操作流程轉向封閉式、自動化和標準化的工作流程。檢查室正優先採用磁珠萃取方法、微流體技術、預填充試劑盒和整合式「樣本到結果」系統，以降低污染風險並縮短週轉時間。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過最佳化實驗方案、預測性維護、異常檢測和自動化品管，對 DNA 和 RNA 樣本製備產生越來越顯著的影響。 AI 驅動的檢查室軟體可以偵測擷取失敗，將樣本品質指標與定序效能關聯起來，並支援高通量設施的動態調度。

主要區域趨勢

亞太地區是成長最快的需求中心之一，這主要得益於中國、日本、印度、韓國、澳洲和東南亞國協定序能力、感染疾病監測和精準醫療基礎設施的擴展。此外，各國基因組學舉措、癌症檢測的增加、大學定序資源的普及以及試劑、儀器和實驗室自動化平台國內生產能力的提升，也為該地區的成長提供了支持。

關鍵群體特定見解

東協地區的需求主要受醫院檢查室、公共衛生監測、學術基因組學以及新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國私營診斷市場成長的推動。該地區需要經濟高效且性能穩定的萃取試劑盒、簡化的核酸純化方法以及能夠在各種基礎設施環境下運作的自動化設備，同時支援感染疾病、腫瘤和生殖健康檢測。

主要國家的概況

美國在臨床NGS、腫瘤伴隨診斷、生物製藥研究和高通量定序中心的引入方面處於主導，從而推動了對自動化核酸提取、樣品製備和檢體品管的需求。加拿大受益於覆蓋全國的研究網路、省級精準醫療課程以及強大的基因組學學術實力。另一方面，墨西哥正透過加強公立和私立實驗室以及傳染病檢查的能力建設來擴展分子診斷。巴西擁有拉丁美洲規模最大的基因組學和感染疾病研究環境，並獲得大學、參考實驗室、公共衛生機構以及專注於腫瘤學的分子檢測機構的支持。

為行業領導者提供的實用建議

產業領導者應投資於可實現自動化的試劑、針對低輸入量和劣化樣品的檢驗工作流程，以及能夠與實驗室資訊管理系統 (LIMS) 和電子品管系統整合的儀器。產品應針對與新一代定序 (NGS)、定量 PCR (qPCR)、數位 PCR、分子診斷和多組體學等技術的兼容性進行最佳化，而非僅針對單一應用。

調查方法

本執行摘要基於二手研究，檢驗資訊來源包括監管機構、國家基因組計劃、同行評審的科學文獻、公共衛生機構、臨床實驗室標準以及公開的產品和工作流程文件。本分析著重於可觀察的推廣促進因素、技術演進、政策趨勢和檢查室工作流程需求，而非檢驗的市場預測。

結論

DNA和RNA樣本製備正從單純的檢查室輔助流程轉變為對分子檢測性能產生重大影響的策略性決定因素。隨著定序和PCR工作流程日益分散和臨床應用日益重要，對標準化、自動化、污染控制和數據整合的樣本製備系統的需求也日益成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 DNA/RNA 樣品製備市場：依產品類型分類

  • 裝置
    • 自動化工作站
    • 離心機
  • 成套工具
    • 樣品製備工具包
      • DNA文庫建構試劑盒
      • RNA文庫建構試劑盒
    • 核酸萃取試劑盒
  • 試劑
    • 緩衝溶液
    • 酵素

第8章：DNA/RNA樣品製備市場：依技術分類

  • 列式法
  • 磁選
  • 降水法

第9章：DNA/RNA樣品製備市場：依樣品類型分類

  • 血
  • 組織
  • 細胞
  • 微生物樣本

第10章：DNA/RNA樣品製備市場：依應用領域分類

  • 臨床診斷
    • 基因檢測
    • 感染疾病
  • 法醫學
    • DNA指紋圖譜
    • RNA分析
  • 研究
    • 基因組學
    • 轉錄組學

第11章 DNA/RNA 樣本製備市場：依最終用戶分類

  • 學術機構
    • 研究機構
    • 大學
  • 生技公司
    • 生物製藥公司
    • 生技新創企業
  • 醫院
    • 臨床檢查室
    • 診斷中心
  • 製藥公司
    • 大型製藥企業
    • 學名藥公司

第12章：DNA/RNA樣品製備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：DNA/RNA樣品製備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 DNA/RNA 樣本製備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agilent Technologies, Inc.
  • Akonni Biosystems, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bioneer Corporation
  • Danaher Corporation
  • Eppendorf SE
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • MP Biomedicals, LLC
  • New England Biolabs, Inc.
  • Norgen Biotek Corp.
  • Omega Bio-tek, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Sage Science, Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-4348D129FA47

The DNA-RNA Sample Preparation Market is projected to grow by USD 4.56 billion at a CAGR of 9.49% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.42 billion
Estimated Year [2026] USD 2.63 billion
Forecast Year [2032] USD 4.56 billion
CAGR (%) 9.49%

DNA-RNA sample preparation is the enabling layer behind next-generation sequencing (NGS), PCR/qPCR, digital PCR, molecular diagnostics, cell and gene therapy research, liquid biopsy, infectious disease surveillance, and multi-omics workflows. Reliable nucleic acid extraction, purification, fragmentation, target enrichment, depletion, and library preparation determine whether downstream instruments generate clinically and scientifically valid results.

For technology suppliers, the market is shaped by demand for higher yield from low-input samples, reproducibility across FFPE tissue and plasma, and compatibility with automated workstations. Growth is supported by expanding genomics programs, decentralized molecular testing, oncology biomarker adoption, and the continued use of RNA-based analysis in transcriptomics and pathogen detection.

Transformative Shifts in the Sample Preparation Landscape

The landscape is shifting from manual, technician-dependent protocols to closed, automated, and standardized workflows. Laboratories are prioritizing magnetic bead-based extraction, microfluidics, prefilled reagent cartridges, and integrated sample-to-answer systems to reduce contamination risk and improve turnaround time.

Another major shift is the move from single-analyte testing to multi-omics and multi-target workflows. Sample preparation products must now support DNA, RNA, circulating tumor DNA, microbial nucleic acids, single-cell material, and degraded FFPE inputs while maintaining chain-of-custody, traceability, and regulatory readiness.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing DNA-RNA sample preparation through protocol optimization, predictive maintenance, anomaly detection, and automated quality control. AI-enabled laboratory software can flag extraction failures, correlate sample quality metrics with sequencing performance, and support dynamic scheduling across high-throughput facilities.

The strongest near-term impact is expected in workflow orchestration rather than full replacement of wet-lab expertise. AI connected with LIMS, robotics, and instrument telemetry can reduce repeat testing, improve reagent utilization, and standardize decisions around sample acceptance, normalization, and library pooling.

Key Regional Insights

Asia-Pacific is one of the fastest-developing demand centers as China, Japan, India, South Korea, Australia, and ASEAN economies expand sequencing capacity, infectious disease surveillance, and precision medicine infrastructure. Regional growth is supported by national genomics initiatives, rising oncology testing, broader university sequencing access, and stronger domestic manufacturing of reagents, instruments, and laboratory automation platforms.

North America remains a core innovation hub due to advanced clinical laboratory networks, FDA-cleared molecular diagnostics, strong publicly funded genomics research, biopharma R&D intensity, and broad adoption of NGS in oncology, inherited disease, pharmacogenomics, and rare disease testing. Europe is shaped by quality standards, the EU In Vitro Diagnostic Regulation, biobank networks, cross-border research programs, and increasing integration of genomic medicine into national health systems, while Latin America is advancing through oncology access, public health laboratories, academic sequencing centers, and reference-lab consolidation.

The Middle East is investing in national genome programs and advanced hospital systems, particularly in GCC markets where precision medicine and population genomics are policy priorities. Africa's opportunity is linked to pathogen genomics, tuberculosis, HIV, malaria research, antimicrobial resistance surveillance, and regional sequencing networks, although cold-chain limitations, procurement cycles, infrastructure variability, and workforce training remain important adoption barriers.

Key Group Insights

ASEAN demand is driven by expanding hospital laboratories, public health surveillance, academic genomics, and growing private diagnostics in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. The region favors cost-effective, robust extraction kits, simplified nucleic acid purification, and automation that can operate across varied infrastructure environments while supporting infectious disease, oncology, and reproductive health testing.

The GCC is distinguished by government-backed precision medicine, population genomics, and high-acuity hospital investments, creating a preference for validated, traceable, and automation-compatible DNA-RNA sample preparation workflows. The European Union emphasizes regulatory compliance, interoperability, and standardized quality systems under IVDR, creating demand for documented sample preparation performance across clinical diagnostics and research. BRICS markets combine large patient populations, public health needs, and domestic manufacturing ambitions, while G7 countries lead in clinical adoption, research funding, high-throughput genomics, and advanced automation. NATO-aligned markets also benefit from biosecurity, pathogen detection, defense-related biosurveillance, and emergency preparedness priorities that require reproducible molecular workflows.

Key Country Insights

The United States leads in clinical NGS adoption, oncology companion diagnostics, biopharma research, and high-throughput sequencing centers, reinforcing demand for automated nucleic acid extraction, library preparation, and sample quality control. Canada benefits from national research networks, provincial precision health programs, and strong academic genomics capacity, while Mexico is expanding molecular diagnostics through public-private laboratory capacity and infectious disease testing. Brazil is Latin America's largest genomics and infectious disease research environment, supported by universities, reference laboratories, public health institutes, and oncology-focused molecular testing.

In Europe, the United Kingdom benefits from national genomic medicine infrastructure and integration of sequencing into health services; Germany combines strong life sciences manufacturing with advanced diagnostics and laboratory automation; France supports national genomic medicine programs and hospital-based molecular testing; Italy and Spain are expanding oncology, inherited disease, and rare disease testing; and Russia maintains demand through public research and clinical laboratories despite supply-chain constraints. China is a major sequencing and reagent manufacturing hub with broad clinical and research genomics activity, India is scaling genomics through national initiatives and private diagnostics, Japan prioritizes quality, automation, and standardized clinical workflows, Australia supports genomics through national research networks and public health sequencing, and South Korea is advancing precision oncology, biotech manufacturing, and digitally integrated laboratory systems.

Actionable Recommendations for Industry Leaders

Industry leaders should invest in automation-ready chemistries, validated workflows for low-input and degraded samples, and instruments that integrate with LIMS and electronic quality systems. Products should be optimized for NGS, qPCR, digital PCR, molecular diagnostics, and multi-omics compatibility rather than isolated applications.

Suppliers should also build regional resilience through dual sourcing, localized technical support, application training, and distributor capability development. Evidence generation is essential: vendors that publish reproducibility data, lot-to-lot performance, sample-type validation, contamination-control measures, and regulatory documentation will be better positioned with clinical, academic, biopharma, and reference laboratories.

Research Methodology

This executive summary is developed using secondary research from verified public sources, including regulatory agencies, national genomics programs, peer-reviewed scientific literature, public health organizations, clinical laboratory standards, and publicly available product and workflow documentation. The analysis prioritizes observable adoption drivers, technology shifts, policy signals, and laboratory workflow requirements rather than unverified market estimates.

Research inputs were triangulated across technology trends, end-user requirements, regional policy signals, procurement patterns, regulatory expectations, and validated use cases in clinical diagnostics, genomics research, biopharma, and public health. Keyword mapping focused on DNA-RNA sample preparation, nucleic acid extraction, NGS library preparation, molecular diagnostics, automation, magnetic bead extraction, FFPE sample preparation, liquid biopsy, and sample quality control.

Conclusion

DNA-RNA sample preparation is moving from a supporting laboratory step to a strategic determinant of molecular testing performance. As sequencing and PCR workflows become more distributed and clinically important, demand will favor standardized, automated, contamination-controlled, and data-connected preparation systems.

Organizations that combine robust chemistry, workflow automation, regulatory documentation, validated performance across difficult sample types, and regional service capabilities will be best positioned across clinical diagnostics, research genomics, biopharma, and public health surveillance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. DNA-RNA Sample Preparation Market, by Product Type

  • 7.1. Instruments
    • 7.1.1. Automated Workstations
    • 7.1.2. Centrifuges
  • 7.2. Kits
    • 7.2.1. Library Preparation Kits
      • 7.2.1.1. DNA Library Kits
      • 7.2.1.2. RNA Library Kits
    • 7.2.2. Nucleic Acid Extraction Kits
  • 7.3. Reagents
    • 7.3.1. Buffers
    • 7.3.2. Enzymes

8. DNA-RNA Sample Preparation Market, by Technology

  • 8.1. Column Based
  • 8.2. Magnetic Separation
  • 8.3. Precipitation

9. DNA-RNA Sample Preparation Market, by Sample Type

  • 9.1. Blood
  • 9.2. Tissue
  • 9.3. Cells
  • 9.4. Microbial samples

10. DNA-RNA Sample Preparation Market, by Application

  • 10.1. Clinical Diagnostics
    • 10.1.1. Genetic Testing
    • 10.1.2. Infectious Diseases
  • 10.2. Forensics
    • 10.2.1. DNA Fingerprinting
    • 10.2.2. RNA Analysis
  • 10.3. Research
    • 10.3.1. Genomics
    • 10.3.2. Transcriptomics

11. DNA-RNA Sample Preparation Market, by End User

  • 11.1. Academic Institutes
    • 11.1.1. Research Institutions
    • 11.1.2. Universities
  • 11.2. Biotechnology Companies
    • 11.2.1. Biopharma Firms
    • 11.2.2. Biotech Startups
  • 11.3. Hospitals
    • 11.3.1. Clinical Labs
    • 11.3.2. Diagnostic Centers
  • 11.4. Pharmaceutical Companies
    • 11.4.1. Big Pharma
    • 11.4.2. Generic Pharma

12. DNA-RNA Sample Preparation Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. DNA-RNA Sample Preparation Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. DNA-RNA Sample Preparation Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Akonni Biosystems, Inc.
  • 16.3. Bio-Rad Laboratories, Inc.
  • 16.4. bioMerieux S.A.
  • 16.5. Bioneer Corporation
  • 16.6. Danaher Corporation
  • 16.7. Eppendorf SE
  • 16.8. Eurofins Scientific SE
  • 16.9. F. Hoffmann-La Roche Ltd.
  • 16.10. GenScript Biotech Corporation
  • 16.11. Illumina, Inc.
  • 16.12. LGC Biosearch Technologies
  • 16.13. Merck KGaA
  • 16.14. MP Biomedicals, LLC
  • 16.15. New England Biolabs, Inc.
  • 16.16. Norgen Biotek Corp.
  • 16.17. Omega Bio-tek, Inc.
  • 16.18. PerkinElmer, Inc.
  • 16.19. Promega Corporation
  • 16.20. QIAGEN N.V.
  • 16.21. Sage Science, Inc.
  • 16.22. Takara Bio Inc.
  • 16.23. Tecan Group Ltd.
  • 16.24. Thermo Fisher Scientific Inc.
  • 16.25. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED WORKSTATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED WORKSTATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED WORKSTATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CENTRIFUGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CENTRIFUGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CENTRIFUGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DNA LIBRARY KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DNA LIBRARY KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DNA LIBRARY KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RNA LIBRARY KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RNA LIBRARY KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RNA LIBRARY KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEIC ACID EXTRACTION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEIC ACID EXTRACTION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEIC ACID EXTRACTION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BUFFERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BUFFERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BUFFERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLUMN BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLUMN BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLUMN BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC SEPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC SEPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PRECIPITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PRECIPITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FORENSICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FORENSICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FORENSICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DNA FINGERPRINTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DNA FINGERPRINTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DNA FINGERPRINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RNA ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RNA ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RNA ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL UNIVERSITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL UNIVERSITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL UNIVERSITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOPHARMA FIRMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPHARMA FIRMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOPHARMA FIRMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOTECH STARTUPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOTECH STARTUPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOTECH STARTUPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CLINICAL LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CLINICAL LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CLINICAL LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIG PHARMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIG PHARMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIG PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GENERIC PHARMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL GENERIC PHARMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL GENERIC PHARMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 245. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 249. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 251. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 255. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 257. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 260. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 296. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 299. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 300. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 302. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 306. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 307. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 308. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 310. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 311. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 312. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 313. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 316. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 318. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 319. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 323. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 324. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 325. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 326. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 327. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 328. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 329. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 330. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 348. CANADA DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 349. CANADA DNA-RNA SAMPLE PREPARATION MARKET SIZE, B